Clinical Trials Browser

Phase 1/2 × INDUSTRY × peginterferon alfa-2a × Clear all

NCT07288112 2026-04-14

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

Phase 1/2 Recruiting

Melanoma